课题基金 / 基金详情

The Role of the Major Alternaria Allergen Alt_a_1 in Airway Inflammation

The Role of the Major Alternaria Allergen Alt_a_1 in Airway Inflammation
主要链格孢过敏原 Alt_a_1 在气道炎症中的作用
批准号:
8313847
负责人:
Christopher Brian Lawrence
金额:
$19.6万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-05 至 2013-07-31

项目摘要

项目成果

Christopher Brian Lawrence的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哮喘中的气道炎症反应可能是免疫细胞对环境因素(如空气传播的真菌)失调的结果。该项目的长期目标是更好地了解哮喘中th2型气道炎症的病理生理机制。长期以来,暴露于真菌交替菌(Alternaria)与人类哮喘的发展和恶化有关。在鼻内暴露于Alternaria孢子和单个蛋白后,幼稚小鼠表现出明显的嗜酸性气道炎症,对无害抗原的Th2增敏增强,以及气道高反应性。尽管Alternaria在过敏性气道疾病(如哮喘)的发展、发病和加重中具有充分的临床重要性,但关于单个真菌产物在这些病理状态中的作用的知识却很少。过敏原摄取和通过上皮细胞层移动(内吞作用和胞吞作用)的重要性和详细机制尚未深入探讨。这个创新项目的重点是分泌的主要交流过敏原Alt_a_1。本研究将通过支气管肺泡上皮细胞和小鼠气道炎症模型来评估Alt_a_1在变应性疾病中的作用。我们已经发现Alt_a_1具有促炎作用,并且含有一个独特的氨基酸基序(RXLR),有助于与细胞表面PI-3-P结合并进入细胞。在目的1中,将研究Alt_a_1在体外和小鼠哮喘模型的先天和适应性免疫反应中的作用。我们将研究重组Alt_a_1蛋白和缺乏Alt_a_1的真菌敲除突变体的影响。在特定的目的2中,Alt_a_1的酯酶活性和RXLR基序在细胞进入和免疫反应中的重要性将被表征。重组Alt_a_1将用于确定酯酶活性、PI-3-P结合和细胞进入所需的氨基酸残基。将研究Alt_a_1蛋白治疗后上皮细胞的免疫反应。该项目将有助于更好地理解持续和复发性气道炎症的机制,并可能导致更具体和有效的治疗和预防策略的发展,特别是如果pi -3- p介导的细胞进入被证明对致敏性具有普遍重要性。
英文摘要
DESCRIPTION (provided by applicant): The inflammatory airway response in asthma may be the result of immune cells that are dysregulated towards environmental factors such as airborne fungi. The long-term goal of this project is to better understand the pathophysiological mechanisms of Th2-type airway inflammation in asthma. Exposure to the fungus, Alternaria, has long been implicated in the development and exacerbation of human asthma. After intranasal exposure to Alternaria spores and individual proteins, naive mice exhibit marked eosinophilic airway inflammation, enhanced Th2 sensitization to innocuous antigens, and airway hyperreactivity. Despite the well-documented clinical importance of Alternaria in the development, onset, and exacerbation of allergic airway diseases such as asthma, little knowledge exists about the role of individual fungal products in these pathological states. The importance of and detailed mechanisms of allergen uptake and movement through the epithelial cell layer (endocytosis and transcytosis) have not been explored to any great extent. This innovative project focuses on the secreted major Alternaria allergen Alt_a_1. It will assess the role of Alt_a_1 in allergic disease by utilizing bronchoalveolar epithelial cells and murine models of airway inflammation. We have discovered that Alt_a_1 is proinflammatory and harbors a unique amino acid motif (RXLR) that facilitates binding to cell surface PI-3-P and cellular entry. In aim 1 the role of Alt_a_1 in innate and adaptive immune responses in vitro and in murine models of asthma will be investigated. The effects of recombinant Alt_a_1 protein and fungal knockout mutants lacking Alt_a_1 will be examined. In specific aim 2 the importance of the Alt_a_1's esterase activity and RXLR motif in cellular entry and immunological responses will be characterized. Recombinant Alt_a_1 will be used to define amino acid residues required for esterase activity, for PI-3-P binding, and for cellular entry. Epithelial cell immune responses following treatment with the Alt_a_1 proteins will be investigated. This project will lead to a better understanding of the mechanisms of persistent and recurrent airway inflammation and may lead to the development of more specific and effective therapies and prevention strategies, especially if PI-3-P-mediated cell entry proves of general importance to allergenicity.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
The Role of the Major Alternaria Allergen Alt_a_1 in Airway Inflammation
海外基金